• Intraoperative strategies include shorter duration of surgery, judicious and monitored use of neuromuscular blocking agents, and lung protective ventilation.
• Postoperative strategies include effective analgesia, early mobilization, and lung expansion techniques. Age is an independent risk factor for development of PPCs even after adjustment for co-morbid conditions. 1, 3, 5 Compared with patients aged <50 years, those >80 years old have an odds ratio (OR) of 5.63 [confidence interval (CI) 4.62-6.84] for developing pneumonia. 5 Potential mechanisms include their lack of physiological reserve, higher airway closing capacity, and lower ventilation-perfusion ratios, leading to hypoxaemia. The patient's ASA status predicts PPCs in those ASA II or greater. [1] [2] [3] 5 Functional dependency and poor general health, unsurprisingly, are important predictors of PPCs. 3, 5 Total dependence (the inability to perform any activity of daily living) more than doubles the patient's likelihood of developing pneumonia (OR 2.83, CI 1.98-2.87). 5 Current smokers have up to a six-fold incidence of PPCs compared with those who have never smoked, although more recent studies suggest a smaller increase in risk (OR 1.28, CI 1.17-1.42) in those smoking within 1 year of surgery. 5, 6 Smokers produce more mucus, have slower mucus clearance, increased airway sensitivity, and increased pulmonary epithelial permeability and impaired macrophage and natural killer cytotoxic activity. Pulmonary adverse events are primarily bronchospasm, laryngospasm, cough, and hypoxaemia. A recent upper respiratory tract infection (URTI) causes increased airway reactivity, changes in pulmonary function, and impairment of immunity caused by the infection itself or by antibiotic use. 8 Those patients suffering an URTI in the month before surgery have an increased risk of PPC (OR 5.5, CI 2.6-11.5). 8 It is prudent to delay elective surgery in symptomatic patients and those taking antibiotic therapy. Congestive heart failure, chronic obstructive pulmonary disease (COPD), and renal failure are co-morbidities frequently associated with pulmonary complications. 1, 3, 5, 6 Good quality evidence identifies congestive heart failure as a significant risk factor for PPCs. 3 COPD has been identified as a common and important risk factor for PPCs (OR 1.79, CI 1.44-2.22) compared with those with healthy lungs. 3, 5 Patients with COPD suffer exacerbation of bronchial inflammation following instrumentation of the airway. The combination of bacterial colonization of their airways, surgery-induced immunosuppression, and increased work of breathing may make COPD patients more susceptible.
Respiratory failure results from fatigue, leaky alveolar-capillary barrier associated with sepsis, or fluid overload and heart failure. 
Postoperative pulmonary complications following non-cardiothoracic surgery postoperative rates of respiratory failure, mechanical ventilation, and prolonged length of stay on intensive care. Surprisingly, no convincing link has been found between obesity and PPCs, even in the morbidly obese. 3 However, obesity hypoventilation syndrome (obesity, awake arterial hypercapnia, and sleep-disordered breathing that may include OSA) is associated with postoperative complications. It is likely that reduced functional residual capacity (FRC) and elevated airway closing capacity lead to atelectasis and postoperative hypoxaemia. Well-controlled asthma is not associated with an increased risk of PPCs. 1, 3 Delirium, alcohol use, and weight loss >10% may be linked to a moderate increase in PPCs as is disseminated cancer. 3, 4 There is insufficient evidence to link exercise capacity, diabetes, or HIV infection. 3 Investigations A serum albumin <30 g l À1 is an important predictor of PPCs, probably because it indicates poor nutrition and chronic poor health, which are both associated with expiratory muscle weakness leading to pulmonary complications. However, the prognostic value of hypoalbuminaemia and nutritional support such as total parenteral nutrition has not been shown to offer any advantage in reducing PPCs. 3, 9 Weaker evidence links PPCs and impaired renal function (serum creatinine >220 mmol l À1 , blood urea nitrogen >7.5 mmol l À1 ), and low haemoglobin <100 g l À1 . Low preoperative oxygen saturations on air (Sp O2 <96%)
are also associated weakly with PPCs but linked more strongly when Sp O2 <90%.
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Chest radiographs are of little value in determining the risk of PPCs, even if abnormal, but should be considered in those with altered symptoms, requiring ventilator support, and in cardiovascular surgery. Spirometry is useful for diagnosing and quantifying COPD. Literature suggests that abnormal spirometry (FEV 1 :FVC <50%) may identify patients at higher risk of PPCs, but data are mixed. Spirometry is not an effective independent predictor of individual risk for PPCs in noncardiothoracic surgery. 1 
Intraoperative risk factors
Changes in pulmonary physiology Anaesthetic agents diminish respiratory drive and the response to hypoxia and hypercapnia, resulting in hypoventilation. In a spontaneously ventilating patient, the closing capacity approaches FRC and the small airways collapse causing atelectasis in the dependent regions of the lung. Hypoxaemia can result from ventilation-perfusion mismatching and increased shunt fraction. Prolonged periods of 100% oxygen may produce absorption atelectasis as all the oxygen is absorbed and the splinting effect of nitrogen in the alveoli is lost.
Following surgery, particularly abdominal and thoracic, pain may limit respiratory excursion and cause splinting of the diaphragm, further reducing FRC and vital capacity. There may be disruption of neurally mediated diaphragmatic function after handling abdominal viscera that also reduces FRC and contributes to atelectasis and collapse. In these circumstances, the patient breathes rapidly and with smaller tidal volumes. The effects of anaesthesia, bed rest, and opioids inhibit the cough reflex and impair respiratory tract ciliary activity, while dry gases result in mucus plugging. These physiological effects contribute to the development of PPCs.
Anaesthetic factors
General anaesthesia had an increased risk for PPCs compared with regional anaesthesia or regional and general anaesthesia combined in a meta-analysis of randomized studies (OR 1.83, CI 1.35-2.46), although many of the included studies were criticized. 1 The combination of general anaesthesia, supine positioning, opiates, and residual neuromuscular block reduces lung volumes and causes atelectasis in a spontaneously ventilating patient. This may be the mechanism that causes PPCs. Poor use of Neuromuscular blocking agents (NMBAs), by failure to monitor correctly or excessive dosing, is associated with an increased risk of PPCs. Despite the common use of reversal agents, residual neuromuscular block (defined as a train of four ratio of <0.9) frequently persists after general anaesthesia. Residual neuromuscular block is associated with impaired upper airway dilator muscle function, impaired cough and swallow reflexes, and airway collapse. Patients are hence predisposed to aspiration and respiratory failure. There is a dosedependent association between NMBAs and post-extubation hypoxia, respiratory failure, negative pressure-induced pulmonary oedema, and atelectasis. 10 Strong evidence also demonstrates that residual neuromuscular block or failure to adequately antagonize NMBAs results in physiological pulmonary impairment, distortion of upper airway anatomy and function, and increased risk of PPCs.
Surgical factors
The surgical site and the duration of surgery (>3 h) influence the risk of developing PPCs. 1 Prolonged surgery and anaesthesia alters immune defence and gas exchange capacity by depressing alveolar macrophage function, interfering with surfactant production, slowing mucociliary clearance, and increasing the permeability of the alveolar-capillary barrier. Abdominal and thoracic and head and neck surgeries are the most likely to interfere with respiratory function and are strongly linked to PPCs, particularly in the context of tissue trauma, fluid shifts, and blood transfusion. Other types of surgery associated with increased risk of PPCs include neurosurgery, with a likely reason being reduced conscious level and the associated risk of aspiration. Vascular and emergency surgeries are also associated, perhaps because of the higher risk patient cohort. Peripheral and orthopaedic procedures are considered to be lower risk for PPCs.
Strategies to reduce postoperative pulmonary complications

Preoperative strategies
Optimizing patient's respiratory disease can reduce PPCs. In COPD, inhaled beta-2 agonists and anticholinergics should be continued in patients already using these medications. Preoperative use of inhaled bronchodilators may improve pulmonary function and maintain the postoperative respiratory function (Table 3) . 11 Short-term treatment with systemic or inhaled corticosteroids can improve lung function preoperatively. Antibiotics should be prescribed only when infection is present (new or changed sputum, positive microbiology, new or changed lung opacities, fever, white blood cell count >12 Â 10 9 litre À1 ). Asthmatics should continue treatment to achieve their best possible peak flow prior to surgery. In severe OSA, preoperative continuous positive airway pressure (CPAP) may be beneficial, as may a mandibular advancement device and weight loss.
Postoperative pulmonary complications following non-cardiothoracic surgery
There is weak evidence that preoperative smoking cessation reduces the incidence of PPCs. The risk of respiratory complications in smokers who quit 2-4 weeks before surgery is similar when compared with current smokers [risk ratio (RR) 1.2]. 11 In patients who cease smoking >4 weeks prior to surgery, there is a slight decrease in PPCs when compared with current smokers (RR 0.77, CI 0.61-0.96). After 8 weeks cessation of smoking, patients may reach an incidence of PPCs comparable to nonsmokers. The evidence of benefit from giving up smoking in the short term remains controversial; rates of PPCs may actually be higher in patients who give up smoking within 2 months of surgery. The likely mechanism is the increased mucus production that occurs transiently following cessation. Smoking causes bronchial irritation. Once this irritant is removed, the improved mucociliary activity and reduced coughing contribute to increased mucus production and an increased risk of PPCs. Prehabilitation exercise programmes are a promising new intervention. Inspiratory muscle training (IMT) is a technique commonly achieved by inspiratory threshold pressure loading (the patient is required to generate an inspiratory pressure equal to a negative pressure inside a chamber in order to open the inspiratory valve for flow). The patient's inspiratory muscle strength improves significantly and is preserved in the early postoperative period. This assists lung expansion, which in turn helps generate forceful expiratory manoeuvres for secretion clearance. There is some evidence that preoperative IMT reduces PPCs in the early postoperative period. 2, 12 However, whether other forms of prehabilitation affect the rate of PPCs after non-cardiac surgery is currently less clear. 13 Perioperative dental care and oral chlorhexidine rinse has been shown to reduce postoperative pneumonia in cardiac surgery patients. It has yet to be shown whether this cheap and simple intervention reduces PPCs in non-cardiothoracic surgery.
Intraoperative strategies
Surgical
Minimally invasive surgical techniques may reduce PPCs, particularly in obese patients. 14 In a bariatric population, pulmonary complications were higher following open gastric bypass surgery when compared with laparoscopic gastric bypass (OR 1.92, CI 1.54-2.38). 14 Postulated mechanisms include reduction in blood loss, pain, and inflammation, and quicker respiratory recovery leading to reduced postoperative pain and length of stay. 4 There is also a reduction in atelectasis on chest radiographs after operation. Whether there is a significant reduction in PPCs in a general (non-obese) population is not clear. 4 Routine use of nasogastric tubes has been associated with PPCs. However, they should be used selectively in situations such as postoperative nausea and vomiting, inability to tolerate oral intake, or symptomatic abdominal distension. In these cases, nasogastric decompression improves return of bowel function and may reduce the incidence of PPCs after elective abdominal operations. 15 
Anaesthetic
PPCs may be reduced by 'lung-protective' modes of mechanical ventilation during surgery. 16 Ventilator-associated lung injury involves several mechanisms-alveolar overdistension (volutrauma), increased transpulmonary pressure (barotrauma), and cyclic opening and closing of alveoli (atelectotrauma). Anaesthesia and surgery also cause atelectasis in dependent lung regions, changing the mechanics of regional lung aeration and potentially contributing to PPCs. Lung protective ventilation aims to reduce pulmonary injury caused by mechanical ventilation, while reducing atelectasis. Lower tidal volume ventilation (6-8 ml kg À1 ideal body weight) has been associated with a reduction in PPCs, and positive-end expiratory pressure (PEEP; 6-8 cm H 2 O) may be of benefit. 16 However, more studies are required to establish the optimum level of PEEP, and whether when combined with recruitment manoeuvres (e.g. CPAP of 30 cm H 2 O for 30 s repeated every 30 min during general anaesthesia) and low tidal volume ventilation these lead to a reduction in PPCs. In critical care, reducing the duration that a patient's trachea is intubated is beneficial. An endotracheal tube (ETT) impairs the cough reflex (as does the necessary sedation) and impairs mucociliary flow. The ETT itself allows bacteria to drain into the trachea and distal airways, leading to pneumonia. Although duration of intubation for surgery is shorter than on critical care, it provides another argument that reduced operation time is safer. Future ideas include the use of subglottic secretion drainage, ETT coating with antimicrobial agent, and modified cuff seals, but it remains to be seen whether these innovations offer benefit in the operating theatre.
When NMBAs are used, quantitative neuromuscular monitoring such as acceleromyography reduces the risk of PPCs and is superior to qualitative analysis. Neostigmine reversal has been associated with a dose-dependent increase in the risk of PPCs. 10 While there is a theoretical mechanism of neostigmine causing depolarizing block, the most likely reason for this association is ineffective anaesthetic administration of larger doses of neostigmine used in an attempt to reverse a deep neuromuscular block. Proper use of neostigmine in patients with quantitative neuromuscular monitoring is likely to reduce PPCs. 10 The newer reversal agent sugammadex is reliable at reversing deep neuromuscular block associated with rocuronium and vecuronium, but no studies exist to show that its use reduces PPCs.
Remifentanil is a useful intraoperative agent, reducing the need for muscle relaxation in appropriate cases, but again no studies exist to show that its use reduces the incidence of PPCs. For COPD patients requiring general anaesthesia, volatile agents are effective bronchodilators, apart from desflurane, which can cause coughing, bronchospasm, and laryngospasm. Supraglottic airway devices offer reduced airway irritation compared with ETTs.
Large volumes of intraoperative fluids are associated with pneumonia and pulmonary oedema, resulting in longer hospital stays after major surgery. 19 Goal-directed fluid therapy (using patient-specific haemodynamic goals) prevents excessively liberal or restrictive fluid administration that risks underperfusing vital organs and the surgical site.
Postoperative strategies
Strategies should focus on early mobilization, effective analgesia, lung expansion techniques, and chest physiotherapy. Analgesia is important because pain, particularly from upper abdominal wounds, compromises pulmonary function, coughing, and mobilization, resulting in atelectasis and pneumonia. Postoperative thoracic epidural analgesia may reduce respiratory muscle dysfunction and pain-related hypoventilation in upper abdominal surgery, thereby facilitating early extubation and reducing the risk of respiratory failure. By this mechanism, epidurals may reduce PPCs and seem to be superior to parenteral opioids in preventing PPCs. 3, 4 In patients undergoing open abdominal aortic aneurysm repair, coronary bypass surgery and abdominal surgery, PPCs have been reduced by one-third with the use of thoracic epidural analgesia. 2 Thoracic epidural analgesia may benefit COPD patients undergoing abdominal surgery by reducing the need for parenteral opiates and sedatives, which worsen respiratory depression. Furthermore, they may reduce the work of breathing and facilitate respiratory physiotherapy and lung recruitment manoeuvres. However, the risks of a neuraxial block including pneumothorax, phrenic nerve paralysis, nerve damage, and epidural haematoma should be evaluated. Postoperative epidural seems superior to on-demand delivery of opioids in preventing PPCs. In meta-analyses, epidural opioids reduced atelectasis (RR 0.53, CI 0.33-0.85) but not pneumonia when compared with systemic opioids, and epidural local anaesthetic reduced pulmonary infection (RR 0.36, [0.36, CI] CI 0.21-0.65) but not atelectasis when compared with systemic opioids. 4, 20 Good evidence suggests that lung expansion therapy reduces PPCs after abdominal surgery. 4 Techniques include chest physiotherapy, deep breathing exercises, cough, postural drainage, percussion and vibration, suctioning and ambulation, incentive spirometry, and nasal CPAP. Incentive spirometry may be the most convenient and inexpensive. Early treatment with CPAP in patients who develop postoperative hypoxaemia after major abdominal surgery may reduce the need for intubation and the incidence of pneumonia. 21 CPAP is particularly good for those with OSA or those who cannot manage incentive spirometry or deep breathing exercises. 3 Nasal high-flow oxygen therapy is easily implemented, well-tolerated, and effective for improving postoperative hypoxaemia, but more evidence is required to determine whether it prevents PPCs.
Conclusion
PPCs are a common and significant predictor of patient morbidity and mortality. Anaesthetists are well placed to implement perioperative management strategies to reduce PPCs. Preoperatively these strategies should include optimization of cardiorespiratory disease, early smoking cessation, and prehabilitation exercise programmes. Intraoperatively the focus should be on shorter duration of surgery, careful and quantitatively monitored NMBAs, and lung protective ventilation strategies. Postoperatively effective analgesia and lung expansion techniques including CPAP and physiotherapy can reduce PPCs.
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